Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03NMQ
|
|||
| Former ID |
DIB003844
|
|||
| Drug Name |
131I-CLR-1404
|
|||
| Synonyms |
NM-324; CLR-1404-[124I]; CLR-1404-[125I]; CLR-1404-[131I]; NM-404-[124I]; NM-404-[125I]; NM-404-[131I]; NM-412-[125I]; Radiolabeled phospholipid ether (cancer), Cellectar; Small molecule phospholipid ether analogs (cancer imaging), University of Michigan; Iodine-124-CLR-1404; Iodine-124-NM-404; Iodine-125-CLR-1404; Iodine-125-NM-404; Iodine-125-NM-412; Iodine-131-CLR-1404; Iodine-131-NM-404; 124I-CLR-1404; 124I-NM-404; 125I-CLR-1404; 125I-NM-404; 125I-NM-412
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Company |
University of Michigan
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01898273) Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.